Clinical Trial

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2019-10-10; most recent amendment 2025-09-29.
Status change: Enrolling by Invitation → Active, Not Recruiting 2023-10-31
Status change: Recruiting → Enrolling by Invitation 2021-07-15
Status change: Not Yet Recruiting → Recruiting 2019-11-06
Trial Details
NCT Number NCT04124406
Lead Sponsor Exact Sciences Corporation
Collaborators: Mayo Clinic
Conditions Colon Cancer
Enrollment 150,000 participants
Start Date 2019-10-18
Primary Completion 2023-12-31 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-03